Studies on Pasteurella multocida. VI. Nature of Systemic Immunity and Analysis of the Correlation between Levels of Immunity Induced by Various Fowl Cholera Vaccines and Protection against Challenge

1978 ◽  
Vol 22 (4) ◽  
pp. 748 ◽  
Author(s):  
S. K. Dua ◽  
S. K. Maheswaran
2019 ◽  
Author(s):  
S. Akter ◽  
C. N. Shampa ◽  
M. A. Islam ◽  
A. U. Alam ◽  
M. Hadiuzzaman ◽  
...  

Background: Duck cholera is an acute, fatal, septicemic disease of domestic ducks which is responsible for significant loss in duck population. The present study was conducted to compare the immunogenicity of two formalin killed fowl cholera vaccines (BAU-FCV and DLS-FCV) in indigenous ducks. Methods: The experimental ducks were divided into three groups (A=15, B=15 and C =10 ducks) of which birds of Group A and Group B were inoculated with 0.5 ml of BAU-FCV and DLS-FCV, respectively through subcutaneous route at the age of 10 weeks whereas ducks of group C were kept as unvaccinated control. Booster vaccination was done with same dose and route at 14 weeks of age. Challenge infection was conducted after 2 weeks of booster vaccination. Results: The mean PHA antibody titres on 15 days post vaccination (DPPV), 28 DPPV, 15 days postsecondary vaccination (DPSV), 28 DPSV and 15 days post challenge were 25.60 ± 3.92, 51.20 ± 7.84, 89.60 ± 15.68, 166.40 ± 38.40 and 204.80 ± 31.35, respectively in ducks of Group A whereas, the mean antibody titres in ducks of Group B were 25.60 ± 3.92, 44.80 ± 7.84, 64.00 ± 7.53,102.40 ± 15.68 and 179.20 ± 31.35 at 15 DPPV, 28 DPPV, 15 DPSV, 28 DPSV and 15 days after challenge, respectively. In this investigation, slightly higher immune responses were observed in ducks of Group A vaccinated with BAU-FCV compare to ducks of Group B vaccinated with DLS-FCV. Birds of both vaccinated groups conferred 100% protection against challenge infection with virulent Pasteurella multocida whereas, 100% mortality was observed in control ducks after challenge. Conclusion: Both vaccines were found to be safe and effective for the vaccination of indigenous ducks against duck cholera.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Rine Christopher Reuben ◽  
Shovon Lal Sarkar ◽  
Habiba Ibnat ◽  
Md. Ali Ahasan Setu ◽  
Pravas Chandra Roy ◽  
...  

AbstractPasteurella multocida causes fowl cholera, a highly contagious poultry disease of global concern, causing significant ecological and economic challenges to the poultry industry each year. This study evaluated the effects of novel multi-strain probiotics consisting of Lactobacillus plantarum, L. fermentum, Pediococcus acidilactici, Enterococcus faecium and Saccharomyces cerevisiae on growth performance, intestinal microbiota, haemato-biochemical parameters and anti-inflammatory properties on broilers experimentally challenged with P. multocida. A total of 120 birds were fed with a basal diet supplemented with probiotics (108 CFU/kg) and then orally challenged with 108 CFU/mL of P. multocida. Probiotics supplementation significantly (P < 0.05) improved growth performance and feed efficiency as well as reducing (P < 0.05) the population of intestinal P. multocida, enterobacteria, and mortality. Haemato-biochemical parameters including total cholesterol, white blood cells (WBC), proteins, glucose, packed cell volume (PCV) and lymphocytes improved (P < 0.05) among probiotic fed birds when compared with the controls. Transcriptional profiles of anti-inflammatory genes including hypoxia inducible factor 1 alpha (HIF1A), tumor necrosis factor- (TNF) stimulated gene-6 (TSG-6) and prostaglandin E receptor 2 (PTGER2) in the intestinal mucosa were upregulated (P < 0.05) in probiotics fed birds. The dietary inclusion of the novel multi-strain probiotics improves growth performance, feed efficiency and intestinal health while attenuating inflammatory reaction, clinical signs and mortality associated with P. multocida infection in broilers.


Author(s):  
Teferi Mandado

This paper was done starting from February 2017 to July 2017 in Jimma University College of Agriculture and School of Veterinary Medicine. The suffering of different animal species from multiple infectious agents in and around the university leads us to be conscious and enabled us to write this scientific paper which can be acts as the source of information for Veterinary vaccinology. Louis Pasteur in the 19th century demonstrated the ability to protect chickens against fowl cholera (Pasteurella multocida) and thus demonstrated the benefit of vaccination in animals and paved the way for the development of the array of veterinary vaccines which are in use today. Since Pasteur’s work, vaccination against infectious disease have been used successfully to protect animals from many serious diseases some of which were also significant risks to humans. Veterinary vaccine has a parallel way of development in research and development of vaccines in the human field vaccinology today also. Vaccine is a biological preparation that improves immunity to a particular disease. Vaccine contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe or its toxins. The general information concerning veterinary vaccination such as common vaccination, common methods of veterinary vaccination, principles of vaccination; standardization of veterinary vaccines, generation of vaccine, vaccine formulation, new approaches to veterinary vaccines and few other information were roughly reviewed from scientific journals, experiment results, proceedings, reference books and manuals. The objectives of this paper are to highlight the general current information of Veterinary Vaccinology and to give specific recommendations based on the facts obtained.


2018 ◽  
Vol 15 (2) ◽  
pp. 91-95
Author(s):  
M. R. Hossain ◽  
M. M. Meher ◽  
M. Afrin

The present study was undertaken to determine the present status of fowl cholera (FC) infection of poultry in Gazipur district during September 2016 to February 2017. A total of 282 either dead or sick birds (Layer and Sonali) were taken as sample in which the sick birds were subjected to record clinical data and consequently the dead birds were for post mortem examination. Hence, overall 12.41% prevalence was found for FC and about 87.59% was for mixed other diseases.  All the birds were grouped into six named as A1, A2 and up to A6 accordingly their age. The highest incidence (29.79 %) was found in A1 (8-20weeks) group and the lowest was 4.26% in A5 (51-60 weeks) group. Furthermore, six FC infected farms were categorized to treat with six specific antibiotics individually. Thereafter, the highest recovery rate (89.6% and 87.5%) was recorded in two farms using Enrofloxacin and Gentamicin particularly. The lowest recovery rate (60%) was in Erythromycin treatment group. However, the layer birds of six farms lost their body weight almost 11.84%, specifically the highest percentages (16.49%) was in treated with Ampicillin and lowest percentages (5.79%) found in a farm treated with Gentamicin. In brief, FC commonly appears just near to laying age and therapeutic management trivially decreases the body weight that ultimately shoots up the production cost.


2013 ◽  
Vol 2 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Samina Ievy ◽  
Mohammad Ferdousur Rahman Khan ◽  
Md Ariful Islam ◽  
Md Bahanur Rahman

The research work was performed for the isolation and identification of Pasteurella multocida from field cases, preparation of oil adjuvanted vaccine from isolated strain and determination of its efficacy. Samples were collected from suspected dead birds of three poultry farms of Bangladesh (Code name: M and R). The P. multocida isolates were Gram negative, non-motile, non- spore forming rod occurring singly or pairs and occasionally as chains or filaments. Biochemically P. multocida ferment basic sugar and consistently produced acid except from maltose and lactose. After isolation formalin killed oil adjuvanted Fowl cholera vaccine was prepared in Laboratory of the Department of Microbiology and Hygiene, BAU and this experimental vaccine (3.2x108 CFU/ml) was administered in nine weeks old White Leg Horn chickens at the different dose rate through intramuscular (IM) route in each selected group A (1ml alum precipitated vaccine), B (0.5ml alum precipitated vaccine), C (1ml oil adjuvanted vaccine) and D (0.5ml oil adjuvanted vaccine). Pre-vaccinated sera were collected from all groups of birds. The mean of Passive Hemagglutination (PHA) titers of post-vaccination were 51±17.8, 76.8±17, 89.6±17, and 115±17.81 in group A, B, C and D respectively which consist of 5 birds in each. The vaccine produced better immune response when boostering with the similar dose and route at 15 days after primary vaccination. The mean PHA titers were higher at group D than other groups after boostering. Challenge infection was conducted on all the vaccinated and control group (n=5) of birds after 15 days of vaccination which protect 93.75% of birds and the PHA titers from different groups analyzed to determine the protective capacity of vaccinated chickens against challenge exposure. It was demonstrated that experimental oil adjuvanted fowl cholera vaccine with 0.5ml dose produce higher immune response against challenge infection and found to be safe. Microbes and Health, June 2013, 2(1): 1-4DOI: http://dx.doi.org/10.3329/mh.v2i1.17253


2010 ◽  
Vol 78 (9) ◽  
pp. 3669-3677 ◽  
Author(s):  
Marina Harper ◽  
Andrew D. Cox ◽  
Frank St. Michael ◽  
Mark Ford ◽  
Ian W. Wilkie ◽  
...  

ABSTRACT Pasteurella multocida is the causative agent of a number of diseases in animals, including fowl cholera. P. multocida strains simultaneously express two lipopolysaccharide (LPS) glycoforms (glycoforms A and B) that differ only in their inner core structure. Glycoform A contains a single 3-deoxy-d-manno-octulosonic acid (Kdo) residue that is phosphorylated by the Kdo kinase, KdkA, whereas glycoform B contains two unphosphorylated Kdo residues. We have previously shown that P. multocida mutants lacking the heptosyltransferase, HptA, produce full-length glycoform B LPS and a large amount of truncated glycoform A LPS, as they cannot add heptose to the glycoform A inner core. These hptA mutants were attenuated in chickens because the truncated LPS made them vulnerable to host defense mechanisms, including antimicrobial peptides. However, here we show that birds inoculated with high doses of the hptA mutant developed fowl cholera and the P. multocida isolates recovered from diseased birds no longer expressed truncated LPS. Sequencing analysis revealed that the in vivo-derived isolates had mutations in kdkA, thereby suppressing the production of glycoform A LPS. Interestingly, a number of the spontaneous KdkA mutant strains produced KdkA with a single amino acid substitution (A112V, R123P, H168Y, or D193N). LPS structural analysis showed that complementation of a P. multocida kdkA mutant with wild-type kdkA restored expression of glycoform A to wild-type levels, whereas complementation with any of the mutated kdkA genes did not. We conclude that in P. multocida KdkA, the amino acids A112, R123, H168, and D193 are critical for Kdo kinase function and therefore for glycoform A LPS assembly.


Sign in / Sign up

Export Citation Format

Share Document